Proactive Diagnostics: The New Frontier in Patient Monitoring
The Power of Proactive Treatment
Managing Complexity Through Collaboration
I also attended sessions on managing immune checkpoint inhibitor–related myocarditis and other cardiovascular complications associated with newer cancer therapies. Sessions on such topics underscored the limitations of standard protocols in these complex cases. This highlights the critical need for close interdisciplinary collaboration. I observed how mature health systems are successfully building dedicated cardio-oncology teams, a model I believe we must replicate in Singapore. Ensuring every patient’s care team includes both an oncologist and a dedicated cardiologist is essential for optimal management.
A Call for Global Inclusion and Asian Data
The conference also served as a platform to address the need for greater global inclusion in cardio-oncology research. There was a strong call for more studies involving Asian populations, whose data remain underrepresented in major trials. As a cardiologist in Singapore, I recognise our responsibility to contribute to this field and intend to pursue multicenter collaborations that better reflect our region’s unique patient profiles.
Our Vision: A Future Without Compromise
Ultimately, our objective is to ensure that no patient undergoing cancer treatment has to compromise their cardiovascular health for their survival. The ESC conference has provided both the validation and the momentum to advance this vision through dedicated and comprehensive care.